NCT04351386View on ClinicalTrials.gov

Validation Study of the Watch HWA09 and Its Softwares ECG-SW1 and PPG-SW1 for the Detection of Atrial Fibrillation

CompletedOBSERVATIONAL

Enrollment

283

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

April 7, 2021

Study Completion Date

April 7, 2021

Conditions

Atrial FibrillationArrythmia, Cardiac

Interventions

DEVICE

AF Detection

Recording PPG and single-lead ECG signals with the Withings HWA09 and ECG signal for the reference 12-lead ECG

Trial Locations (3)

75008

Institut Cœur Paris Centre Turin, Paris

75015

Hopital Europeen Georges Pompidou, Paris

93200

Centre Cardiologique du Nord, Saint-Denis

All Listed Sponsors

lead

Withings

INDUSTRY

NCT04351386 - Validation Study of the Watch HWA09 and Its Softwares ECG-SW1 and PPG-SW1 for the Detection of Atrial Fibrillation | Biotech Hunter | Biotech Hunter